|Chronic rapamycin treatment on the nutrient utilization and metabolism of juvenile turbot (Psetta maxima)|Wang, Q.; He, G.; Mai, K.; Xu, W.; Zhou, H.; Wang, X.; Mei, L. (2016). Chronic rapamycin treatment on the nutrient utilization and metabolism of juvenile turbot (Psetta maxima). NPG Scientific Reports 6(28068): 8 pp. hdl.handle.net/10.1038/srep28068
In: Scientific Reports (Nature Publishing Group). Nature Publishing Group: London. ISSN 2045-2322, more
Metabolism; Psetta maxima (Linnaeus, 1758) [WoRMS]; Marine
|Authors|| || Top |
- Wang, Q.
- He, G.
- Mai, K.
- Xu, W.
- Zhou, H.
- Wang, X.
- Mei, L.
High dietary protein inclusion is necessary in fish feeds and also represents a major cost in the aquaculture industry, which demands improved dietary conversion into body proteins in fish. In mammals, the target of rapamycin (TOR) is a key nutritionally responsive molecule governing postprandial anabolism. However, its physiological significance in teleosts has not been fully examined. In the present study, we examined the nutritional physiology of turbot after chronic rapamycin inhibition. Our results showed that a 6-week inhibition of TOR using dietary rapamycin inclusion (30?mg/kg diet) reduced growth performance and feed utilization. The rapamycin treatment inhibited TOR signaling and reduced expression of key enzymes in glycolysis, lipogenesis, cholesterol biosynthesis, while increasing the expression of enzymes involved in gluconeogenesis. Furthermore, rapamycin treatment increased intestinal goblet cell number in turbot, while the expressions of Notch and Hes1 were down regulated. It was possible that stimulated goblet cell differentiation by rapamycin was mediated through Notch-Hes1 pathway. Therefore, our results demonstrate the important role of TOR signaling in fish nutritional physiology.